Immunis, Inc.
Immunis is a clinical stage regenerative medicine biotech developing a unique stem cell-derived biologic, a novel multi-active therapy targeting dysregulated immune-associated muscle aging and metabolic decline.
)
January 11-14, 2027 | San Francisco
January 11-14, 2027 | San Francisco
)
)
January 11-14, 2027 | San Francisco
){kind=logo}
){kind=logo}
)